Canada on Saturday reported a second case of uncommon blood clots with low platelets after immunization with AstraZeneca’s COVID-19 vaccine in every week, whereas it mentioned it nonetheless really useful the usage of the shot.
The one who skilled the very uncommon occasion has been handled and is recovering, Canada’s well being ministry mentioned in a press release, including that the individual lives within the province of Alberta.
Primarily based on the proof out there, Canada nonetheless maintains that the advantages of the AstraZeneca vaccine outweigh the potential dangers, the assertion mentioned.
Canada well being authorities “will proceed to observe the usage of all COVID-19 vaccines carefully and study and assess any new security considerations,” the assertion mentioned.
Canada reported a primary blood clotting related to the vaccine on Tuesday, and a day later, after a overview, well being authorities mentioned they might not limit use of the AstraZeneca vaccine.
A separate advisory council had earlier really useful Canada cease providing the vaccine to individuals beneath 55. That panel is within the means of reviewing its recommendation.
Canada has been ramping up its vaccination marketing campaign, however nonetheless has a smaller proportion of its inhabitants inoculated than dozens of different international locations, together with the USA and Britain.
Amid a spiking third wave of infections, Ontario, Canada’s most populous province, introduced new public well being restrictions on Friday, together with closing the provinces borders to home vacationers.